Related party transactions (Details Narrative) - EUR (€) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| IfrsStatementLineItems [Line Items] | ||
| Management fees | € 50,602 | € 19,933 |
| Research and development costs | 8,159 | 3,015,598 |
| Davion Healthcare Plc [Member] | ||
| IfrsStatementLineItems [Line Items] | ||
| Management fees | 0 | 1,100,000 |
| Research and development costs | 1,707,178 | |
| Davion Healthcare Plc 1 [Member] | ||
| IfrsStatementLineItems [Line Items] | ||
| Management fees | € 400,000 | 600,000 |
| Research and development costs | 556,279 | |
| Entities with joint control or significant influence over entity [member] | ||
| IfrsStatementLineItems [Line Items] | ||
| Sales and marketing expense | 287,000 | |
| Davion Healthcare Plc 2 [Member] | ||
| IfrsStatementLineItems [Line Items] | ||
| Management fees | € 77,415 | |